메뉴 건너뛰기




Volumn 15, Issue 4, 2002, Pages 729-740

New treatment strategies in childhood acute lymphoblastic leukaemia

Author keywords

Childhood ALL; Leukaemia; MRD; Prognostic factors; Treatment

Indexed keywords

ASPARAGINASE; CYCLOPHOSPHAMIDE; CYTARABINE; DAUNORUBICIN; DEXAMETHASONE; IMMUNOGLOBULIN; MERCAPTOPURINE; METHOTREXATE; PREDNISONE; T LYMPHOCYTE RECEPTOR; VINCRISTINE;

EID: 0036954974     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.2002.0226     Document Type: Review
Times cited : (16)

References (44)
  • 1
    • 0028152851 scopus 로고
    • Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86
    • Reiter A, Schrappe M, Ludwig W-D et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. Blood 1994; 84: 3122-3133.
    • (1994) Blood , vol.84 , pp. 3122-3133
    • Reiter, A.1    Schrappe, M.2    Ludwig, W.-D.3
  • 2
    • 0028204905 scopus 로고
    • Treatment of childhood acute lymphoblastic leukemia: Results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01
    • Schorin MA, Blattner S, Gelber RD et al. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. Journal of Clinical Oncology 1994; 12: 740-747.
    • (1994) Journal of Clinical Oncology , vol.12 , pp. 740-747
    • Schorin, M.A.1    Blattner, S.2    Gelber, R.D.3
  • 3
    • 0028813641 scopus 로고
    • Intensification of treatment and survival in all children with lymphoblastic leukaemia: Results of UK Medical Research Council trial UKALL X
    • Chessells JM, Bailey C & Richards SM. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Lancet 1995; 345: 143-148.
    • (1995) Lancet , vol.345 , pp. 143-148
    • Chessells, J.M.1    Bailey, C.2    Richards, S.M.3
  • 5
    • 0032482394 scopus 로고    scopus 로고
    • Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy
    • Nachman JB, Sather HN, Sensel MG et al. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy. New England Journal of Medicine 1998; 338: 1663-1671.
    • (1998) New England Journal of Medicine , vol.338 , pp. 1663-1671
    • Nachman, J.B.1    Sather, H.N.2    Sensel, M.G.3
  • 6
    • 0034517924 scopus 로고    scopus 로고
    • Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995
    • Schrappe M, Reiter A, Zimmermann M et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Leukemia 2000; 14: 2205-2222.
    • (2000) Leukemia , vol.14 , pp. 2205-2222
    • Schrappe, M.1    Reiter, A.2    Zimmermann, M.3
  • 7
    • 0025071916 scopus 로고
    • Results and significance of six randomized trials in four consecutive ALL-BFM trials
    • Riehm H, Gadner H, Henze G et al. Results and significance of six randomized trials in four consecutive ALL-BFM trials. Haematology and Blood Transfusion 1990; 33: 439-450.
    • (1990) Haematology and Blood Transfusion , vol.33 , pp. 439-450
    • Riehm, H.1    Gadner, H.2    Henze, G.3
  • 8
    • 0027406656 scopus 로고
    • Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: A Children's Cancer Group phase III trial
    • Tubergen DG, Gilchrist GS, O'Brien RT et al. Improved outcome with delayed intensification for children with acute lymphoblastic leukemia and intermediate presenting features: a Children's Cancer Group phase III trial. Journal of Clinical Oncology 1993; 11: 527-537.
    • (1993) Journal of Clinical Oncology , vol.11 , pp. 527-537
    • Tubergen, D.G.1    Gilchrist, G.S.2    O'Brien, R.T.3
  • 9
    • 0031798867 scopus 로고    scopus 로고
    • Prophylaxis and treatment of meningeosis in childhood acute lymphoblastic leukemia
    • Schrappe M, Reiter A & Riehm H. Prophylaxis and treatment of meningeosis in childhood acute lymphoblastic leukemia. Journal of Neuro-Oncology 1998; 38: 159-165.
    • (1998) Journal of Neuro-Oncology , vol.38 , pp. 159-165
    • Schrappe, M.1    Reiter, A.2    Riehm, H.3
  • 10
    • 0023186011 scopus 로고
    • Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83)
    • Riehm H, Reiter A, Schrappe M et al. Die Corticosteroid-abhängige Dezimierung der Leukämiezellzahl im Blut als Prognosefaktor bei der akuten lymphoblastischen Leukämie im Kindesalter (Therapiestudie ALL-BFM 83). [The in vivo response on corticosteriod therapy as an additional prognostic factor in childhood acute lymphoblastic leukemia (therapy study ALL-BFM 83).] Klinische Pädiatrié 1987; 199: 151-160.
    • (1987) Klinische Pädiatrié , vol.199 , pp. 151-160
    • Riehm, H.1    Reiter, A.2    Schrappe, M.3
  • 11
    • 0034210549 scopus 로고    scopus 로고
    • Improved outcome in childhood ALL despite reduced use of anthracyclines and of cranial radiotherapy: Results of trial ALL-BFM 90
    • Schrappe M, Reiter A, Ludwig W-D et al. Improved outcome in childhood ALL despite reduced use of anthracyclines and of cranial radiotherapy: results of trial ALL-BFM 90. Blood 2000; 95: 3310-3322.
    • (2000) Blood , vol.95 , pp. 3310-3322
    • Schrappe, M.1    Reiter, A.2    Ludwig, W.-D.3
  • 12
    • 0029118138 scopus 로고
    • Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia
    • Gajjar A, Ribeiro R, Hancock ML et al. Persistence of circulating blasts after 1 week of multiagent chemotherapy confers a poor prognosis in childhood acute lymphoblastic leukemia. Blood 1995; 86: 1292-1295.
    • (1995) Blood , vol.86 , pp. 1292-1295
    • Gajjar, A.1    Ribeiro, R.2    Hancock, M.L.3
  • 13
    • 9044244144 scopus 로고    scopus 로고
    • Cytoreduction and prognosis in acute lymphoblastic leukemia - The importance of early marrow response: Report from the Childrens Cancer Group
    • Steinherz PG, Gaynon PS, Breneman JC et al. Cytoreduction and prognosis in acute lymphoblastic leukemia - the importance of early marrow response: report from the Childrens Cancer Group. Journal of Clinical Oncology 1996; 14: 389-398.
    • (1996) Journal of Clinical Oncology , vol.14 , pp. 389-398
    • Steinherz, P.G.1    Gaynon, P.S.2    Breneman, J.C.3
  • 14
    • 0030720796 scopus 로고    scopus 로고
    • Early response to therapy and outcome in childhood acute lymphoblastic leukemia: A review
    • Gaynon PS, Desai AA, Bostrom BC et al. Early response to therapy and outcome in childhood acute lymphoblastic leukemia: a review. Cancer 1997; 80: 1717-1726.
    • (1997) Cancer , vol.80 , pp. 1717-1726
    • Gaynon, P.S.1    Desai, A.A.2    Bostrom, B.C.3
  • 15
    • 0347184138 scopus 로고    scopus 로고
    • Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
    • Coustan-Smith E, Behm FG, Sanchez J et al. Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia. Lancet 1998; 351: 550-554.
    • (1998) Lancet , vol.351 , pp. 550-554
    • Coustan-Smith, E.1    Behm, F.G.2    Sanchez, J.3
  • 16
    • 0032576355 scopus 로고    scopus 로고
    • Prognostic value of minimal residual disease in childhood acute lymphoblastic leukemia: A prospective study of the International BFM Study Group
    • van Dongen JJM, Seriu T, Panzer-Grumayer ER et al. Prognostic value of minimal residual disease in childhood acute lymphoblastic leukemia: a prospective study of the International BFM Study Group. Lancet 1998; 352: 1731-1738.
    • (1998) Lancet , vol.352 , pp. 1731-1738
    • van Dongen, J.J.M.1    Seriu, T.2    Panzer-Grumayer, E.R.3
  • 17
    • 0033757970 scopus 로고    scopus 로고
    • Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group
    • Biondi A, Valsecchi MG, Seriu T et al. Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group. Leukemia 2000; 14: 1939-1943.
    • (2000) Leukemia , vol.14 , pp. 1939-1943
    • Biondi, A.1    Valsecchi, M.G.2    Seriu, T.3
  • 18
    • 0034141517 scopus 로고    scopus 로고
    • Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia
    • Panzer-Grumayer ER, Schneider M, Panzer S et al. Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia. Blood 2000; 95: 790-794.
    • (2000) Blood , vol.95 , pp. 790-794
    • Panzer-Grumayer, E.R.1    Schneider, M.2    Panzer, S.3
  • 19
    • 0035102296 scopus 로고    scopus 로고
    • MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: Outcome prediction strongly depends on the therapeutic regimen
    • zur Stadt U, Harms DO, Schluter S et al. MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen. Leukemia 2001; 15: 283-285.
    • (2001) Leukemia , vol.15 , pp. 283-285
    • zur Stadt, U.1    Harms, D.O.2    Schluter, S.3
  • 20
    • 0037082505 scopus 로고    scopus 로고
    • Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome
    • Nyvold C, Madsen HO, Ryder LP et al. Precise quantification of minimal residual disease at day 29 allows identification of children with acute lymphoblastic leukemia and an excellent outcome. Blood 2002; 99: 1253-1258.
    • (2002) Blood , vol.99 , pp. 1253-1258
    • Nyvold, C.1    Madsen, H.O.2    Ryder, L.P.3
  • 21
    • 9044226139 scopus 로고    scopus 로고
    • Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia
    • Smith M, Arthur D, Camitta B et al. Uniform approach to risk classification and treatment assignment for children with acute lymphoblastic leukemia. Journal of Clinical Oncology 1996; 14: 18-24.
    • (1996) Journal of Clinical Oncology , vol.14 , pp. 18-24
    • Smith, M.1    Arthur, D.2    Camitta, B.3
  • 22
    • 8944251627 scopus 로고    scopus 로고
    • Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM 90 and CoALL-05-92
    • Schlieben S, Borkhardt A, Reinisch I et al. Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM 90 and CoALL-05-92. Leukemia 1996; 10: 957-963.
    • (1996) Leukemia , vol.10 , pp. 957-963
    • Schlieben, S.1    Borkhardt, A.2    Reinisch, I.3
  • 23
    • 79960970708 scopus 로고    scopus 로고
    • Improved risk-adapted treatment of childhood ALL with a new stratification system based on early response, genetics, age, and WBC: First interim analysis of trial ALL-BFM 95
    • Schrappe M, Reiter A, Harbott J et al. Improved risk-adapted treatment of childhood ALL with a new stratification system based on early response, genetics, age, and WBC: first interim analysis of trial ALL-BFM 95. Blood 2001; 98: 718a.
    • (2001) Blood , vol.98
    • Schrappe, M.1    Reiter, A.2    Harbott, J.3
  • 24
    • 0037100416 scopus 로고    scopus 로고
    • Improved outcome in high risk childhood acute lymphoblastic leukemia defined by prednisone poor response treated with double BFM Protocol II
    • Aricò M, Valsecchi MG, Conter V et al. Improved outcome in high risk childhood acute lymphoblastic leukemia defined by prednisone poor response treated with double BFM Protocol II. Blood 2002; 100: 420-426.
    • (2002) Blood , vol.100 , pp. 420-426
    • Aricò, M.1    Valsecchi, M.G.2    Conter, V.3
  • 25
    • 16944366700 scopus 로고    scopus 로고
    • Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response
    • Foroni L, Coyle LA, Papaioannou M et al. Molecular detection of minimal residual disease in adult and childhood acute lymphoblastic leukaemia reveals differences in treatment response. Leukemia 1997; 11: 1732-1741.
    • (1997) Leukemia , vol.11 , pp. 1732-1741
    • Foroni, L.1    Coyle, L.A.2    Papaioannou, M.3
  • 26
    • 0030967508 scopus 로고    scopus 로고
    • T cell receptor Ddelta2Ddelta3 rearrangement: A suitable allele-specific marker for the detection of minimal residual disease in childhood acute lymphoblastic leukemia
    • Seriu T, Erz D, Stark Y & Bartram CR. T cell receptor Ddelta2Ddelta3 rearrangement: a suitable allele-specific marker for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia 1997; 11: 759-761.
    • (1997) Leukemia , vol.11 , pp. 759-761
    • Seriu, T.1    Erz, D.2    Stark, Y.3    Bartram, C.R.4
  • 27
    • 0037097740 scopus 로고    scopus 로고
    • Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL
    • Willemse MJ, Seriu T, Hettinger K et al. Detection of minimal residual disease identifies differences in treatment response between T-ALL and precursor B-ALL. Blood 2002; 99: 4386-4393.
    • (2002) Blood , vol.99 , pp. 4386-4393
    • Willemse, M.J.1    Seriu, T.2    Hettinger, K.3
  • 28
    • 0032572924 scopus 로고    scopus 로고
    • Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia
    • European Organization for Research and Treatment of Cancer - Childhood Leukemia Cooperative Group
    • Cave H, van der Werff ten Bosch J, Suciu S et al. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia. European Organization for Research and Treatment of Cancer - Childhood Leukemia Cooperative Group. New England Journal of Medicine 1998; 339: 591-598.
    • (1998) New England Journal of Medicine , vol.339 , pp. 591-598
    • Cave, H.1    van der Werff ten Bosch, J.2    Suciu, S.3
  • 29
    • 0037085750 scopus 로고    scopus 로고
    • Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia
    • Dworzak MN, Froschl G, Printz D et al. Prognostic significance and modalities of flow cytometric minimal residual disease detection in childhood acute lymphoblastic leukemia. Blood 2002; 99: 1952-1958.
    • (2002) Blood , vol.99 , pp. 1952-1958
    • Dworzak, M.N.1    Froschl, G.2    Printz, D.3
  • 30
    • 0027494884 scopus 로고
    • Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: A follow-up report of the Childrens Cancer Group Study CCG-106
    • Gaynon PS, Steinherz PG, Bleyer WA et al. Improved therapy for children with acute lymphoblastic leukemia and unfavorable presenting features: a follow-up report of the Childrens Cancer Group Study CCG-106. Journal of Clinical Oncology 1993; 11: 2234-2242.
    • (1993) Journal of Clinical Oncology , vol.11 , pp. 2234-2242
    • Gaynon, P.S.1    Steinherz, P.G.2    Bleyer, W.A.3
  • 32
    • 12944293123 scopus 로고    scopus 로고
    • Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: A BFM group report
    • Reiter A, Schrappe M, Ludwig WD et al. Intensive ALL-type therapy without local radiotherapy provides a 90% event-free survival for children with T-cell lymphoblastic lymphoma: a BFM group report. Blood 2000; 95: 416-421.
    • (2000) Blood , vol.95 , pp. 416-421
    • Reiter, A.1    Schrappe, M.2    Ludwig, W.D.3
  • 33
    • 0032532289 scopus 로고    scopus 로고
    • + childhood acute lymphoblastic leukemia: Good initial steroid response allows early prediction of a favorable treatment outcome
    • + childhood acute lymphoblastic leukemia: good initial steroid response allows early prediction of a favorable treatment outcome. Blood 1998; 92: 2730-2741.
    • (1998) Blood , vol.92 , pp. 2730-2741
    • Schrappe, M.1    Arico, M.2    Harbott, J.3
  • 34
    • 0034611661 scopus 로고    scopus 로고
    • Outcome of treatment in children with Philadelphia chromosome- positive acute lymphoblastic leukemia
    • Arico M, Valsecchi MG, Camitta B et al. Outcome of treatment in children with Philadelphia chromosome- positive acute lymphoblastic leukemia. New England Journal of Medicine 2000; 342: 998-1006.
    • (2000) New England Journal of Medicine , vol.342 , pp. 998-1006
    • Arico, M.1    Valsecchi, M.G.2    Camitta, B.3
  • 35
    • 0036606506 scopus 로고    scopus 로고
    • Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region
    • Pui CH, Gaynon PS, Boyett JM et al. Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 chromosomal region. Lancet 2002; 359: 1909-1915.
    • (2002) Lancet , vol.359 , pp. 1909-1915
    • Pui, C.H.1    Gaynon, P.S.2    Boyett, J.M.3
  • 36
    • 0029781907 scopus 로고    scopus 로고
    • Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome
    • Bührer C, Hartmann R, Fengler R et al. Peripheral blast counts at diagnosis of late isolated bone marrow relapse of childhood acute lymphoblastic leukemia predict response to salvage chemotherapy and outcome. Journal of Clinical Oncology 1996; 14: 2812-2817.
    • (1996) Journal of Clinical Oncology , vol.14 , pp. 2812-2817
    • Bührer, C.1    Hartmann, R.2    Fengler, R.3
  • 37
    • 0035856232 scopus 로고    scopus 로고
    • Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia
    • Eckert C, Biondi A, Seeger K et al. Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia. Lancet 2001; 358 1239-1241.
    • (2001) Lancet , vol.358 , pp. 1239-1241
    • Eckert, C.1    Biondi, A.2    Seeger, K.3
  • 38
    • 0028910836 scopus 로고
    • Gender and treatment outcome in childhood lymphoblastic leukaemia: Report from the MRC UKALL trials
    • Chessells JM, Richards SM, Bailey CC et al. Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials. British Journal of Haematology 1995; 89: 364-372.
    • (1995) British Journal of Haematology , vol.89 , pp. 364-372
    • Chessells, J.M.1    Richards, S.M.2    Bailey, C.C.3
  • 39
    • 0025365178 scopus 로고
    • Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features
    • Gaynon PS, Bleyer WA, Steinherz PG et al. Day 7 marrow response and outcome for children with acute lymphoblastic leukemia and unfavorable presenting features. Medical and Pediatric Oncology 1990; 18: 273-279.
    • (1990) Medical and Pediatric Oncology , vol.18 , pp. 273-279
    • Gaynon, P.S.1    Bleyer, W.A.2    Steinherz, P.G.3
  • 40
    • 0344246893 scopus 로고    scopus 로고
    • Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia
    • Doerdelmann M, Reiter A, Borkhardt A et al. Prednisone response is the strongest predictor of treatment outcome in infant acute lymphoblastic leukemia. Blood 1999; 94: 1209-1217.
    • (1999) Blood , vol.94 , pp. 1209-1217
    • Doerdelmann, M.1    Reiter, A.2    Borkhardt, A.3
  • 41
    • 0026446811 scopus 로고
    • Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: A report of three consecutive studies of the BFM group
    • Reiter A, Schrappe M, Ludwig WD et al. Favorable outcome of B-cell acute lymphoblastic leukemia in childhood: a report of three consecutive studies of the BFM group. Blood 1992; 80: 2471-2478.
    • (1992) Blood , vol.80 , pp. 2471-2478
    • Reiter, A.1    Schrappe, M.2    Ludwig, W.D.3
  • 42
    • 0033571361 scopus 로고    scopus 로고
    • Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: A report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90
    • Reiter A, Schrappe M, Tiemann M et al. Improved treatment results in childhood B-cell neoplasms with tailored intensification of therapy: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90. Blood 1999; 94: 3294-3306.
    • (1999) Blood , vol.94 , pp. 3294-3306
    • Reiter, A.1    Schrappe, M.2    Tiemann, M.3
  • 43
    • 0025099853 scopus 로고
    • More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials
    • Sallan SE, Gelber RD, Kimball V et al. More is better! Update of Dana-Farber Cancer Institute/Children's Hospital childhood acute lymphoblastic leukemia trials. Haematology and Blood Transfusion 1990; 33: 459-466.
    • (1990) Haematology and Blood Transfusion , vol.33 , pp. 459-466
    • Sallan, S.E.1    Gelber, R.D.2    Kimball, V.3
  • 44
    • 0026067393 scopus 로고
    • Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy
    • Rivera GK, Raimondi SC, Hancock ML et al. Improved outcome in childhood acute lymphoblastic leukaemia with reinforced early treatment and rotational combination chemotherapy. Lancet 1991; 337: 61-66.
    • (1991) Lancet , vol.337 , pp. 61-66
    • Rivera, G.K.1    Raimondi, S.C.2    Hancock, M.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.